John Carpenter
Impact in
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
- Ophthalmology top 10%
- Retinal Diseases and Treatments
Papers in
-
- Protein purification and stability 5
-
- Drug Solubulity and Delivery Systems 3
- Co-authors
- Debra Kristensen (2 shared papers)LaToya Jones Braun (2 shared papers)Anil K. Tyagi (2 shared papers)Dexiang Chen (2 shared papers)David Sylvester (2 shared papers)Mark Guy (2 shared papers)Eduardo B. Rodrigues (1 shared paper)Flávio Rezende (1 shared paper)
- Journals
- Human Vaccines (1 paper)Analytical Biochemistry (1 paper)Progress in Retinal and Eye Research (1 paper)Journal of Pharmaceutical Sciences (1 paper)Advances in Archaeological Practice (1 paper)
- Partner nations
- United StatesMexicoCanada
In The Last Decade
John Carpenter
18 papers receiving 346 citations
Peers
Comparison fields: 5 of 104
- Pharmaceutical Science 35
- Ophthalmology 41
- Radiology, Nuclear Medicine and Imaging 77
- Immunology 57
- Molecular Biology 151
Countries citing papers authored by John Carpenter
This map shows the geographic impact of John Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Carpenter more than expected).
Fields of papers citing papers by John Carpenter
This network shows the impact of papers produced by John Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Carpenter. The network helps show where John Carpenter may publish in the future.
Co-authors
The 25 scholars most cited alongside John Carpenter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 77 | |
| 2 | 2010 | 58 | |
| 3 | 2008 | 57 | |
| 4 | 2009 | 57 | |
| 5 | 2019 | 24 | |
| 6 | 2019 | 20 | |
| 7 | 1980 | 19 | |
| 8 | 2008 | 16 | |
| 9 | 2001 | 13 | |
| 10 | 2004 | 10 | |
| 11 | A dictionary of pharmacology and clinical drug evaluation | 1994 | 8 |
| 12 | 1986 | 5 | |
| 13 | 1993 | 3 | |
| 14 | 1998 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2008 | 1 | |
| 18 | Pharmacology from A to Z | 1989 | 1 |
| 19 | 2022 | 0 |
About John Carpenter
John Carpenter is a scholar working on Molecular Biology, Pharmaceutical Science, Epidemiology, Immunology and Anthropology, having authored 19 papers that have together received 375 indexed citations. Recurring topics across this work include Protein purification and stability (5 papers), Drug Solubulity and Delivery Systems (3 papers), Hepatitis B Virus Studies (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Archaeology and Natural History (2 papers), Inhalation and Respiratory Drug Delivery (1 paper), Pneumonia and Respiratory Infections (1 paper) and Food Industry and Aquatic Biology (1 paper). The work is most often cited by research in Pharmaceutical Science (35 citations), Ophthalmology (41 citations), Radiology, Nuclear Medicine and Imaging (77 citations), Immunology (57 citations) and Molecular Biology (151 citations). John Carpenter has collaborated with scholars based in United States, Mexico and Canada. Frequent co-authors include Debra Kristensen, LaToya Jones Braun, Anil K. Tyagi, Dexiang Chen, David Sylvester, Mark Guy, Eduardo B. Rodrigues, Flávio Rezende, Geoffrey G. Emerson and Susumu Uchiyama. Their work appears in journals such as Human Vaccines, Analytical Biochemistry, Progress in Retinal and Eye Research, Journal of Pharmaceutical Sciences and Advances in Archaeological Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.